Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor - Wikidata - wikimedia - TriplyDB

Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor

Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor

http://www.wikidata.org/entity/Q33949063

about

DBC2, a candidate for a tumor suppressor gene involved in breast cancer.PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase.DBC2 resistance is achieved by enhancing 26S proteasome-mediated protein degradation Cyclin D1 down-regulation is essential for DBC2's tumor suppressor function Practical uses for ecdysteroids in mammals including humans: an update Inhibition of neuronal phenotype by PTEN in PC12 cells Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion.Identification of phosphorylated residues on varicella-zoster virus immediate-early protein ORF63.Ecdysone-controlled expression of transgenes.Citrullination of histone H3 interferes with HP1-mediated transcriptional repression.Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.Improving the efficiency of RNA interference in mammals.Pathogenicity of Salmonella: SopE-mediated membrane ruffling is independent of inositol phosphate signals The gene encoding the splicing factor SF2/ASF is a proto-oncogene Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry.Inducible, reversible, and stable RNA interference in mammalian cells.Survival factor NFIL3 restricts FOXO-induced gene expression in cancer The co-chaperone BAG3 regulates Herpes Simplex Virus replication.PTEN deletion leads to up-regulation of a secreted growth factor pleiotrophin.Inducible RNAi system and its application in novel therapeutics.Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.An ecdysone and tetracycline dual regulatory expression system for studies on Rac1 small GTPase-mediated signaling.

P2860

Q24536178-998A676D-DDD8-4AFB-97A1-0CAA39F78E74 Q24563328-BA56F880-2E3E-474A-8048-0476FBDB722D Q24682655-7C76AC19-1C68-4112-A5A4-DEE056A5CC96 Q24683644-4EA37454-364F-45B8-A528-3B01CC91F0B8 Q24806380-5F8AC1BA-CA8F-424E-A5A4-D47DE4B2564D Q28576729-27C217CA-E7EE-46AA-B126-6639FDBF4FD0 Q30537354-4E574775-7131-4EF1-A727-79EC5BF07E77 Q33923143-A8E991F9-7C84-4AAB-9EAB-5EDB04AC2581 Q34134783-950C6249-8F64-46C7-B527-2C5E01093C6E Q34426561-345183A4-E7D4-4C31-9DA1-488200B4A1E9 Q35757521-AEBAE930-F883-4A78-8474-AE2E931484E6 Q35773259-7DD807A2-5CF0-4D17-8C2E-20ADDA6EAA2A Q35842792-7B112490-BE8F-4A59-BF31-83A85657C6BF Q36129226-AA792DD7-6EE4-4FBB-B12E-AD89529B6272 Q36199762-188F8732-1D27-41FD-8B1C-62CED75662AA Q36221055-E23D1796-DE32-403C-A5AD-8D48DFE0E58D Q36604113-72AEF638-4FDB-488B-8565-0374F575E341 Q36832185-45E0E581-AFBD-419B-8F45-8958F306757A Q37016389-91920983-B579-4FD7-9ED4-08DB01D8CA8D Q38315381-814AC04F-B760-4544-89C5-973793CABF1B Q38362040-398C8563-757D-4256-8E4C-5C09056D6E84 Q39421527-9FC0FE6F-7E68-4FF4-9464-CAA5F11C9973 Q40443893-232EE6B2-430C-42B3-8966-4EC857D9C4A0 Q40649363-890DEB5D-97C5-405B-80B2-73F5C58731AF

P2860

Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor

http://www.wikidata.org/entity/Q33949063

description

2001 nî lūn-bûn

@nan

2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Design of a retroviral-mediate ...... g of the PTEN tumor suppressor

@ast

Design of a retroviral-mediate ...... g of the PTEN tumor suppressor

@en

type

label

Design of a retroviral-mediate ...... g of the PTEN tumor suppressor

@ast

Design of a retroviral-mediate ...... g of the PTEN tumor suppressor

@en

prefLabel

Design of a retroviral-mediate ...... g of the PTEN tumor suppressor

@ast

Design of a retroviral-mediate ...... g of the PTEN tumor suppressor

@en

P1433

Q33949063-FC49323A-AD65-4216-ABEB-132C4A985898

P1476

Q33949063-7C733CF3-996F-4899-83DE-0FDD92FEC57D

P2093

Q33949063-01EDF8E8-83BA-48BF-9488-CADD05E2B7EB

Q33949063-0376C476-A8DF-46A8-A8F2-5C76599C7ACF

Q33949063-063A478C-6789-4122-9DC4-090EC8F93761

Q33949063-2CA51AEF-6625-454B-8F1E-D1D1C490265E

Q33949063-586FE8D0-B0C5-483B-9225-DA2925FAAFE4

Q33949063-8C08E0F6-6F46-4B2B-8EF7-3AED75FC743C

Q33949063-BA7E5FFA-D28F-430B-B392-97BD1078C901

P2860

Q33949063-01B61130-9314-49E9-97F5-CB0C61845294

Q33949063-24687143-DACF-498D-957C-A1B5E973736B

Q33949063-378D1672-743E-4308-AE0A-E8F36C897D84

Q33949063-3E737FCB-3F9D-46AE-A21D-5571CCFD9FFE

Q33949063-4211C307-EC79-4C40-91D6-5E95367885AE

Q33949063-710A6A21-5879-4AE1-B9D2-120E5F401B11

Q33949063-7BCB46A2-4AEB-4106-9BBF-063F30A91F49

Q33949063-7F83A4F7-EA4C-4085-98E0-C08E201384AF

Q33949063-853F3EB0-8E5C-475D-A87B-B32C41F77721

Q33949063-8A538DBB-A58B-463A-97E2-14C6F6E6A05C

P304

Q33949063-7902A537-30C2-4594-A4AB-919E3EB9B430

P31

Q33949063-8B223F49-D664-4AC8-B477-F29905CFE2E2

P356

Q33949063-D8EAD4AC-6A60-40E9-A415-B20D7C6C6726

P407

Q33949063-27AF0959-1E99-4317-A1C0-BD3D9A35D535

P433

Q33949063-E5313268-6BE8-47F1-9F91-DD181CE33C5A

P478

Q33949063-028499F0-8353-4B48-A7DF-423767A5E633

P577

Q33949063-50C7B54A-585E-464E-BAF2-D44A75613199

P5875

Q33949063-65F34ED0-9C87-4A32-971F-0E7E16080866

P698

Q33949063-4E986948-C67E-47AA-9751-C1220098F8AC

P932

Q33949063-6BAC56F3-8613-444D-A61C-0A0F73E2E7C0

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Design of a retroviral-mediate ...... g of the PTEN tumor suppressor

@en

P2093

A Reiner

http://www.w3.org/2001/XMLSchema#string

G J Hannon

http://www.w3.org/2001/XMLSchema#string

J Stolarov

http://www.w3.org/2001/XMLSchema#string

K Chang

http://www.w3.org/2001/XMLSchema#string

L Rodgers

http://www.w3.org/2001/XMLSchema#string

M H Wigler

http://www.w3.org/2001/XMLSchema#string

V Mittal

http://www.w3.org/2001/XMLSchema#string

P2860

The lipid phosphatase activity of PTEN is critical for its tumor supressor function

TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

Quantitative monitoring of gene expression patterns with a complementary DNA microarray

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

Myc activates telomerase

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

P304

13043-13048

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.221450598

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11664869

http://www.w3.org/2001/XMLSchema#string

P698

11687610

http://www.w3.org/2001/XMLSchema#string

P932

60821

http://www.w3.org/2001/XMLSchema#string